trending Market Intelligence /marketintelligence/en/news-insights/trending/hx-g-ecrxt_rcp_dwtb75g2 content esgSubNav
In This List

Immune Therapeutics appoints board member

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Immune Therapeutics appoints board member

Immune Therapeutics Inc. appointed Jack Brewer as a board member.

Brewer is the CEO and founder of the Brewer Group Cos. He manages Brewer's private portfolio, which focuses on impact investing.

Immune Therapeutics said that Brewer has assisted in the company's expansion into international markets, such as Malawi and Haiti, and has recently started work to help the company expand registration into India.

Orlando, Fla.-based Immune Therapeutics develops immunotherapies for autoimmune and inflammatory diseases, cancer, HIV/AIDS and animal diseases.